0001104659-21-134639.txt : 20211104 0001104659-21-134639.hdr.sgml : 20211104 20211104212946 ACCESSION NUMBER: 0001104659-21-134639 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211104 FILED AS OF DATE: 20211104 DATE AS OF CHANGE: 20211104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Intelligent Medicine Sponsor LLC CENTRAL INDEX KEY: 0001885142 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41024 FILM NUMBER: 211382017 BUSINESS ADDRESS: STREET 1: 9001 BURDETTE ROAD CITY: BETHESDA STATE: MD ZIP: 20817 BUSINESS PHONE: 202-905-5834 MAIL ADDRESS: STREET 1: 9001 BURDETTE ROAD CITY: BETHESDA STATE: MD ZIP: 20817 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intelligent Medicine Acquisition Corp. CENTRAL INDEX KEY: 0001850051 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 862283527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9001 BURDETTE RD. CITY: BETHESDA STATE: MD ZIP: 20817 BUSINESS PHONE: 202-905-5834 MAIL ADDRESS: STREET 1: 9001 BURDETTE RD. CITY: BETHESDA STATE: MD ZIP: 20817 3 1 tm219664-17_3seq1.xml OWNERSHIP DOCUMENT X0206 3 2021-11-04 0 0001850051 Intelligent Medicine Acquisition Corp. IQMD 0001885142 Intelligent Medicine Sponsor LLC 9001 BURDETTE RD. BETHESDA MD 20817 0 0 1 0 Class B Common Stock Class A Common Stock 4900000 D As described in the issuer's registration statement on Form S-1 (File No. 333-260205) (the "Registration Statement") under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like) and subject to certain anti-dilution rights and have no expiration date. The shares of Class B common stock beneficially owned by the reporting person include up to 675,000 shares subject to forfeiture to the extent the underwriter of the initial public offering of the issuer's securities does not exercise in full its over-allotment option as described in the Registration Statement. /s/ Gregory C. Simon, Manager of Intelligent Medicine Sponsor LLC 2021-11-04